OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 19, 2020
The American Academy of Pediatrics (AAP) has issued its recommendations for the 2020-2021 influenza season.
September 01, 2020
The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.
August 27, 2020
NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.
August 24, 2020
Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.
August 20, 2020
Caregivers of children with ADHD can choose from an increasing number of treatments that can be customized.
June 26, 2020
Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
June 23, 2020
The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.
June 18, 2020
The phase 2/3 trials will evaluate remdesivir (Gilead) in pediatric patients, from newborns to adolescents, who have contracted severe COVID-19 symptoms.
June 17, 2020
EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
May 04, 2020
The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.